Crinetics Pharmaceuticals, Inc. Crinetics Pharmaceuticals, Inc.

Crinetics Pharmaceuticals, Inc.

CRNX

Kedudukan dalam Saham #2195
Crinetics Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical... Crinetics Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical enterprise, dedicated to the identification, advancement, and market introduction of therapeutic solutions for infrequent endocrine conditions and related tumors. Their flagship drug candidate, Paltusotine, is an orally administered, selective, non-peptide somatostatin receptor type 2 agonist. This compound has concluded its Phase III clinical trials for the treatment of acromegaly, and has also completed Phase II trials targeting carcinoid syndrome and nonfunctional neuroendocrine tumors (NETs). Furthermore, the company's pipeline includes CRN04777, an oral selective non-peptide somatostatin type 5 receptor agonist, which is currently undergoing Phase I clinical trials for congenital hyperinsulinism. Another investigational drug, CRN04894, an oral adrenocorticotrophic hormone antagonist, is in Phase I clinical trials for Cushing's disease and congenital adrenal hyperplasia. Crinetics Pharmaceuticals, Inc. was founded in 2008 and maintains its headquarters in San Diego, California.
Harga Saham
$84.95
Disegerakkan terakhir: 2026-09-01
Modal Pasaran
$9.00B
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
110.12%
Negara
US
Perdagangan Crinetics Pharmaceuticals, Inc. (CRNX)

Kategori

Healthcare
Sejarah harga saham bagi Crinetics Pharmaceuticals, Inc. (CRNX)
Harga penutupan tertinggi: $84.95 pada 2026-09-01

Harga penutupan terendah: $24.52 pada 2018-07-01
Sejarah harga saham Crinetics Pharmaceuticals, Inc. dari 2018 hingga 2026
Prestasi harga saham tahunan
Tahun Prestasi
2026 (TTM) 3.89%
2025 -13.25%
2024 59.38%
2023 103.03%
2022 -34.46%
2021 91.75%
2020 -37.94%
2019 -30.68%
2018 0.00%
Harga saham bagi syarikat atau pesaing serupa
Syarikat Harga saham Perubahan 1thn% Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $535.97 25.69%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $190.72 610.32%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $137.83 -3.78%
AU
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $291.76 2.51%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $889.32 9.23%
NL